Baraclude and Generalised oedema - a phase IV clinical study of FDA data

Summary:

Generalised oedema is reported as a side effect among people who take Baraclude (entecavir), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Clinoril, and have Hepatic cirrhosis.

The phase IV clinical study analyzes which people have Generalised oedema when taking Baraclude. It is created by eHealthMe based on reports of 6,115 people who have side effects when taking Baraclude from the FDA, and is updated regularly.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

What is Generalised oedema?

Generalised oedema (swelling all over the body) is found to be associated with 1,089 drugs and 1,406 conditions by eHealthMe. Check the latest studies of Generalised oedema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

6,115 people reported to have side effects when taking Baraclude.
Among them, 11 people (0.18%) have Generalised oedema.

Could Baraclude cause Generalised oedema?

Among these 11 people:

How long have people been on Baraclude when they have Generalised oedema? *

What is the gender of people who have Generalised oedema when taking Baraclude? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Generalised oedema when taking Baraclude? *

What are other drugs people take besides Baraclude? *

What are other side effects people have besides Generalised oedema? *

Acute Kidney Failure: 3 people, 27.27%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 2 people, 18.18%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 2 people, 18.18%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 18.18%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 9.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 9.09%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 9.09%
Cardiac Failure: 1 person, 9.09%
Coagulation Factor V Level Decreased: 1 person, 9.09%
Dyspnea (difficult or laboured breathing): 1 person, 9.09%

What are the existing conditions these people have? *

Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 45.45%

* Approximation only. Some reports may have incomplete information.

Do you take Baraclude and have Generalised oedema?

- Check whether Generalised oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baraclude:

Baraclude (6,175 reports)

Browse all side effects of Baraclude:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Generalised oedema:

Generalised oedema (1,089 drugs)

Browse all the conditions that are associated with Generalised oedema:

Generalised oedema (1,406 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Baraclude) and Baraclude (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.